This is part two of a two part series on pharmaceutical companies and their relationships with the Food and Drug Administration (FDA). Our focus is on the efficacy of prescription drugs as well as the cost for the consumer.
Jonathan Emord, attorney & author of The Rise of Tyranny and Dr. Charles B. Simone speak on the truth about the FDA. An enormous amount of marketing dollars are spent by pharmaceutical companies to market their drugs. Thus, patients learn to demand certain drugs from their doctors. The problem with this is that often times over-the-counter drugs (i.e. Aspirin) or nutrients (i.e. fish oil) will have the same effect on one’s lifespan as a prescription drug.
Jonathan Emord has defeated the FDA six times and is well-versed in the issues surrounding the corruption of the United States health care system. At the center of the FDA issue is that of accountability. The checks and balances that are in place for government are non-existent for the FDA. The FDA Commissioner has the authority to create law (regulations), enforce violations, and judge the violation. The Commissioner of any independent regulatory committee is virtually all-powerful. This means that 3/4 of the laws that are made are not made by representatives in Congress, but they are in fact made by unelected officials. And because of the controversial nature of the committee issues and the fragile nature of congressional elections, congressmen will avoid making the tough decisions and instead diplomatically mail a letter to the regulatory committee.
Another key component to concerns about the FDA is the way that economics play a role in FDA approvals and rejections. Simply put, the government has censored information for solely economic reasons. They further discuss the specifics of how and why they do this and the resulting effect on health care.
To learn more about censorship, Dr. Simone‘s website will provide more information. He will also provide you with the tools to show you what you can do as a consumer to make a difference in these issues.
04.05.09 – 1726